131 related articles for article (PubMed ID: 31552833)
1. Effects of CD133 Silencing on Survival and Migration of HT-29 Colorectal Cancer Cells.
Akbari M; Shanehbandi D; Asadi M; Shomali N; Faraji A; Khaze V; Pakdel A; Mokhtarzadeh A; Ebrahimi AA; Shabani A; Bardaran B
Iran J Immunol; 2019 Sep; 16(3):246-257. PubMed ID: 31552833
[TBL] [Abstract][Full Text] [Related]
2. The combination effect of Prominin1 (CD133) suppression and Oxaliplatin treatment in colorectal cancer therapy.
Asadzadeh Z; Mansoori B; Mohammadi A; Kazemi T; Mokhtarzadeh A; Shanehbandi D; Hemmat N; Derakhshani A; Brunetti O; Safaei S; Aghajani M; Najafi S; Silvestris N; Baradaran B
Biomed Pharmacother; 2021 May; 137():111364. PubMed ID: 33592546
[TBL] [Abstract][Full Text] [Related]
3. CD133 suppression increases the sensitivity of prostate cancer cells to paclitaxel.
Aghajani M; Mokhtarzadeh A; Aghebati-Maleki L; Mansoori B; Mohammadi A; Safaei S; Asadzadeh Z; Hajiasgharzadeh K; Khaze Shahgoli V; Baradaran B
Mol Biol Rep; 2020 May; 47(5):3691-3703. PubMed ID: 32246247
[TBL] [Abstract][Full Text] [Related]
4. BACH1 silencing by siRNA inhibits migration of HT-29 colon cancer cells through reduction of metastasis-related genes.
Davudian S; Shajari N; Kazemi T; Mansoori B; Salehi S; Mohammadi A; Shanehbandi D; Shahgoli VK; Asadi M; Baradaran B
Biomed Pharmacother; 2016 Dec; 84():191-198. PubMed ID: 27657827
[TBL] [Abstract][Full Text] [Related]
5. Salinomycin inhibits metastatic colorectal cancer growth and interferes with Wnt/β-catenin signaling in CD133
Klose J; Eissele J; Volz C; Schmitt S; Ritter A; Ying S; Schmidt T; Heger U; Schneider M; Ulrich A
BMC Cancer; 2016 Nov; 16(1):896. PubMed ID: 27855654
[TBL] [Abstract][Full Text] [Related]
6. ELK3 promotes the migration and invasion of liver cancer stem cells by targeting HIF-1α.
Lee JH; Hur W; Hong SW; Kim JH; Kim SM; Lee EB; Yoon SK
Oncol Rep; 2017 Feb; 37(2):813-822. PubMed ID: 27959451
[TBL] [Abstract][Full Text] [Related]
7. Exosomes from CD133
Zhao H; Chen S; Fu Q
J Cell Biochem; 2020 Jun; 121(5-6):3286-3297. PubMed ID: 31960989
[TBL] [Abstract][Full Text] [Related]
8. The Pinx1 Gene Downregulates Telomerase and Inhibits Proliferation of CD133+ Cancer Stem Cells Isolated from a Nasopharyngeal Carcinoma Cell Line by Regulating Trfs and Mad1/C-Myc/p53 Pathways.
Shen C; Chen F; Wang H; Li G; Yu C; Wang X; Wen Z
Cell Physiol Biochem; 2018; 49(1):282-294. PubMed ID: 30138944
[TBL] [Abstract][Full Text] [Related]
9. The Effect of Metformin on the Proliferation, Apoptosis and CD133 mRNA Expression of Colon Cancer Stem Cells by Upregulation of miR 342-3p.
Zhang Y; Chen R; Deng L; Shuai Z; Chen M
Drug Des Devel Ther; 2021; 15():4633-4647. PubMed ID: 34815662
[TBL] [Abstract][Full Text] [Related]
10. Role of CD44(high)/CD133(high) HCT-116 cells in the tumorigenesis of colon cancer.
Zhou JY; Chen M; Ma L; Wang X; Chen YG; Liu SL
Oncotarget; 2016 Feb; 7(7):7657-66. PubMed ID: 26840024
[TBL] [Abstract][Full Text] [Related]
11. Silencing of CD133 inhibits GLUT1-mediated glucose transport through downregulation of the HER3/Akt/mTOR pathway in colon cancer.
Kim H; Ju JH; Son S; Shin I
FEBS Lett; 2020 Mar; 594(6):1021-1035. PubMed ID: 31736063
[TBL] [Abstract][Full Text] [Related]
12. ABCG2 is required for self-renewal and chemoresistance of CD133-positive human colorectal cancer cells.
Ma L; Liu T; Jin Y; Wei J; Yang Y; Zhang H
Tumour Biol; 2016 Sep; 37(9):12889-12896. PubMed ID: 27449042
[TBL] [Abstract][Full Text] [Related]
13. siRNA-mediated silencing of Nanog reduces stemness properties and increases the sensitivity of HepG2 cells to cisplatin.
Alemohammad H; Motafakkerazad R; Asadzadeh Z; Farsad N; Hemmat N; Najafzadeh B; Vasefifar P; Baradaran B
Gene; 2022 May; 821():146333. PubMed ID: 35182674
[TBL] [Abstract][Full Text] [Related]
14. [LincRNA-ROR functions as a ceRNA to regulate Oct4, Sox2, and Nanog expression by sponging miR-145 and its effect on biologic characteristics of colonic cancer stem cells].
Yan ZY; Sun XC
Zhonghua Bing Li Xue Za Zhi; 2018 Apr; 47(4):284-290. PubMed ID: 29690669
[No Abstract] [Full Text] [Related]
15. Proliferative Activity of Colorectal Cancer Cells with Different Levels of CD133 Expression.
Gisina AM; Kim YS; Potashnikova DM; Tvorogova AV; Yarygin KN; Lupatov AY
Bull Exp Biol Med; 2019 Aug; 167(4):541-545. PubMed ID: 31502129
[TBL] [Abstract][Full Text] [Related]
16. Prostaglandin E2 Promotes Colorectal Cancer Stem Cell Expansion and Metastasis in Mice.
Wang D; Fu L; Sun H; Guo L; DuBois RN
Gastroenterology; 2015 Dec; 149(7):1884-1895.e4. PubMed ID: 26261008
[TBL] [Abstract][Full Text] [Related]
17. Targeting effect of microRNA on CD133 and its impact analysis on proliferation and invasion of glioma cells.
Zhao C; Ma ZG; Mou SL; Yang YX; Zhang YH; Yao WC
Genet Mol Res; 2017 Mar; 16(1):. PubMed ID: 28362995
[TBL] [Abstract][Full Text] [Related]
18. TMPRSS4 correlates with colorectal cancer pathological stage and regulates cell proliferation and self-renewal ability.
Huang A; Zhou H; Zhao H; Quan Y; Feng B; Zheng M
Cancer Biol Ther; 2014 Mar; 15(3):297-304. PubMed ID: 24335200
[TBL] [Abstract][Full Text] [Related]
19. A Validation Study of CD133 as a Reliable Marker for Identification of Colorectal Cancer Stem-Like Cells.
You CZ; Xu H; Zhao FS; Dou J
Bull Exp Biol Med; 2024 Jan; 176(3):369-375. PubMed ID: 38340198
[TBL] [Abstract][Full Text] [Related]
20. [Abnormal expression of APRIL in colorectal cancer cells promotes tumor growth and metastasis].
Wang GH; Lu MH; Wang JC; Wang F; Ding WF; Wang YG; Ju SQ; Wang HM
Zhonghua Zhong Liu Za Zhi; 2013 Apr; 35(4):249-55. PubMed ID: 23985251
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
